Your browser doesn't support javascript.
Reactive mass vaccination campaign against cholera in the COVID-19 context in Cameroon: challenges, best practices and lessons learned.
Amani, Adidja; Fouda, André Arsène Bita; Nangmo, Armanda Jeanne; Bama, Solange Ngo; Tatang, Collins Asaah; Mbang, Marie Angèle; Douba, Emmanuel Christian Epee; Noula, Aimé Gilbert Mbonda; Dia, Mariette; Bouhenia, Malika.
  • Amani A; Sub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
  • Fouda AAB; World Health Organization, Regional Office for Africa, Vaccine-Preventable Disease Unit, Brazzaville, Republic of Congo.
  • Nangmo AJ; Evodoula District Hospital, Evodoula, Cameroon.
  • Bama SN; Muea Medicalized Center, Buea, Cameroon.
  • Tatang CA; Sub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
  • Mbang MA; Sub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
  • Douba ECE; National Operating Office, Disease Prevention and Control Office, Emergency Preparedness and Control Office, World Health Organization Country Office, Yaoundé, Cameroon.
  • Noula AGM; Community Epidemic and Pandemic Preparedness, International Federation of Red Cross and Red Crescent Societies Cluster Support Team, Central Africa Region, Yaoundé, Cameroon.
  • Dia M; World Health Organization Africa Office, Brazzaville, Republic of Congo.
  • Bouhenia M; World Health Organization Main Office, Geneva, Switzerland.
Pan Afr Med J ; 38: 392, 2021.
Article in English | MEDLINE | ID: covidwho-1928884
ABSTRACT

INTRODUCTION:

since 1971, Cameroon is facing a growing series of cholera epidemics despite all the efforts made by the government to address this huge public health threat. In 2020, in addition to the COVID-19 pandemic, Cameroon recorded a high cholera case fatality rate of 4.3% following epidemics noted in the South, Littoral and South-West regions. The Cameroon Ministry of Public Health, has thus organized a reactive vaccination campaign against cholera to address the high mortality rate in the affected health districts of those regions. The objective of this study was to describe the challenges, best practices and lessons learned drawing from daily experiences from this reactive vaccination campaign against cholera.

METHODS:

we conducted a cross-sectional study drawn from the results of the campaign. We had a target population of 631,109 participants aged 1 year and above resident of the targeted health areas.

RESULTS:

the overall vaccination coverage was 64.4% with a refusal rate ranging from 0-10% according to health districts. Vaccination coverage was the lowest among people aged 20 years and above. The main challenge was difficulty maintaining physical distanciation, the main best practice was the screening of all actors taking part at the vaccination against COVID-19 and we found that emphasizing on thorough population sensitization through quarter heads and social mobilizers and adequately programming the campaign during a good climate season is crucial to achieving good vaccination coverage.

CONCLUSION:

lessons learned from this study could serve to inform various agencies in the event of planning rapid mass vaccination programs during pandemics.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cholera Vaccines / Cholera / Mass Vaccination / COVID-19 Type of study: Observational study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2021 Document Type: Article Affiliation country: Pamj.2021.38.392.27754

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cholera Vaccines / Cholera / Mass Vaccination / COVID-19 Type of study: Observational study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2021 Document Type: Article Affiliation country: Pamj.2021.38.392.27754